[The specific features of the clinical course of tuberculosis and enhancement of its treatment efficiency in fertile-age women with iron-deficiency anemia].
One hundred and twenty-three female patients aged 16 to 49 years with pulmonary tuberculosis were examined and followed up. Of them, 83 (67.5%) patients in whom tuberculosis had occurred and run in the presence of iron-deficiency anemia (IDA) made up a study group and 40 (32.5%) patients in whom tuberculosis had occurred without IDA formed a control group. In the women from the study group, the clinical manifestations of the disease had its own peculiarities: a less pronounced temperature reaction, meager expectoration, severe signs of hypoxia (dyspnea), and chest pain and 97% were found to have abnormally shaped red blood cells (poikilocytosis). Inclusion of Tardiferon into complex treatment aids in enhancing the efficiency of treatment for tuberculosis in the presence of IDA, promoting to a greater extent the regression of the clinical manifestations of the disease and the achievement of abacillation than cicatrization.
Mukhtarov
D Z
DZ
Sultanova
R A
RA
D000293:Adolescent; D000328:Adult; D018798:Anemia, Iron-Deficiency / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D004359:Drug Therapy, Combination; D005260:Female; D005296:Ferrous Compounds / Q000627:therapeutic use*; D005298:Fertility; D005500:Follow-Up Studies; D006801:Humans; D007501:Iron / Q000097:blood; D008875:Middle Aged; D009077:Mucins / Q000627:therapeutic use*; D016896:Treatment Outcome; D014397:Tuberculosis, Pulmonary / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D055815:Young Adult
D000995:Antitubercular Agents; D003692:Delayed-Action Preparations; D004338:Drug Combinations; D005296:Ferrous Compounds; D009077:Mucins; C009380:ferrous sulfate, mucin drug combination; D007501:Iron